SPIRE Therapeutics, Inc.
PrivateLast Round
Accelerator
Aug 27, 2024
Company Overview
SPIRE Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Salt Lake City, Utah. Its latest recorded funding round was an Accelerator round in August 2024.
SPIRE Therapeutics, Inc. is a therapeutic devices company that develops noninvasive ultrasound-based neuromodulation technology for the treatment of neurological disorders such as chronic pain and depression.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SPIRE Therapeutics, Inc. Comparables
Compare SPIRE Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Attune Neurosciences | 87% | |
| Openwater | 81% | |
| Neurosona | 78% |
For institutional investors. Book with your work email.
SPIRE Therapeutics, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SPIRE Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Accelerator |
| Altitude Lab | Accelerator |
| Wilson Sonsini Goodrich & Rosati | Accelerator |
| Wellcome Trust | Accelerator |
| National Science Foundation | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2024
Led by Altitude Lab with participation from Focused Ultrasound Foundation.
For institutional investors. Book with your work email.
SPIRE Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SPIRE Therapeutics, Inc.'s valuation, stock price, and market status.
Is SPIRE Therapeutics, Inc. a public or private company?
SPIRE Therapeutics, Inc. is a private company.
What is the current stock price of SPIRE Therapeutics, Inc.?
SPIRE Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks SPIRE Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SPIRE Therapeutics, Inc. worth (valuation)?
Valuation information for SPIRE Therapeutics, Inc. is not publicly available.
Can I buy SPIRE Therapeutics, Inc. stock?
SPIRE Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SPIRE Therapeutics, Inc.'s last funding round?
SPIRE Therapeutics, Inc.'s most recent funding round was Accelerator on August 27, 2024.
Who are the main investors in SPIRE Therapeutics, Inc.?
Key investors in SPIRE Therapeutics, Inc. include Altitude Lab.
Will SPIRE Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for SPIRE Therapeutics, Inc..
How can I track SPIRE Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in SPIRE Therapeutics, Inc.'s shares on secondary markets.